pressures (OBPs) (SBPՆ140mmHg or DBPՆ90mmHg) at two visits with at least 2 week interval. And at the third study visit, we measured 3 consecutive OBPs. baPWV was used to assess aortic stiffness and measured using a volume-plethysmographic device (form PWV/ABI; Colin Co., Ltd., Japan). Carotid PS was assessed using 7.5-MHz B-mode ultrasonography. Lesions with an Intima-media thickness Ն1.1mm were defined as atheromatous plaques. Its score was calculated as summing all plaque thicknesses in both carotid systems. The associations of PS with age, sex, height, body mass index, hypercholesterolemia, diabetes, smoking habits, baPWV, mean 3 consecutive OBPs (mean BP) and pulse pressure (mean PP) were assessed by multiple regression analysis.
P-678 DIABETES MELLITUS AND HYPERTENSION IN ELDERLY AFRICAN AMERICANS: ARE WE MEETING THE RECOMMENDED GOALS?
Akomolafe A Abimbola, Oguniyi Modele, Ugochi Ohuabunwa. Internal Medicine, Morehouse School of Medicine, Atlanta, GA, United States. Background: Epidemiologic studies suggest that lower blood pressure treatment goals may have potential benefits for diabetics with hypertension. The blood pressure treatment goal for diabetics without macroalbuminuria is less than 130/85 mm Hg and less than 125/75 mm Hg for patients with diabetes and nephrotic syndrome. However, hypertension control in elderly African Americans with diabetes remains a challenge.
Objective: To determine the prevalence of hypertension among elderly African American patients with diabetes and to evaluate the prevalence of uncontrolled hypertension in this population.
Methods: A cross-sectional medical review of medical records for elderly diabetic patients receiving care between January 1 2003 and 30 December 2003 in a large, urban public hospital (Grady Memorial Hospital). The medical records of identified patients will be obtained and data will be abstracted by a trained coordinator.
Patient Population: Study subjects will consist of patients with a diagnosis of DM. We define DM as causal plasma glucose greater than or equal to 11.1mmol/l recorded at baseline examination, the use of insulin or hypoglycemic drug therapy and physician documented history of DM. Subjects identified as being diabetics will have their medical records reviewed for a diagnosis of Hypertension. We define as hypertension as blood pressure greater than 130/85 mm Hg in subjects without macroalbuminuria and 125/75 mm Hg for patients with diabetes and nephritic syndrome.
Inclusion criteria will comprise the following: Both male and female patients age Ͼ65 years of age and those all should be African Americans.
Results: Patients in this populations were less likely to meet the treatment goals for blood pressure management.
Conclusion:
Studies have shown that controlling blood pressure in diabetics can lead to reduction in all cause mortality, myocardial infarction (MI), stroke, congestive heart failure (CHF) and microvascular diseases in diabetes. Interventions to improve blood pressure management in elderly diabetics are important to help reduce negative health consequences. 
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P-679 THE ADJUNCTIVE EFFECT OF CANDESARTAN TREATMENT IN HYPERTENSIVE PATIENTS WITH RESPONDER BLOOD PRESSURE REDUCTION
Background:
The block of the renin-angiotensin system is one of the most significant hypertensive treatment. Monotherapy frequently of the angiotensin II receptor antagonists does not cause adequate blood pressure (BP) reduction.
Methods: We performed ambulatory BP monitoring (ABPM) twice before and after once-daily dose of candesartan therapy in 42 hypertensive patients and measured plasma and urine levels of neurohumoral factors. We compared the ABPM levels of the first time before and after a treatment and, on the other hand, compared the ABPM levels of the second time before and after a treatment. Therefore we reviewed it in 84 examples in total. Morning BP was defined as the average BP during the first 2h after waking.
Results: Candesartan reduced clinic, 24h and morning systolic BP and diastolic BP (pϽ0.001). There were sixteen nonresponders for treatment. A baseline BP-dependent BP reduction was found for morning SBP (rϭ-0.41, pϽ0.001) but was not found for 24hr SBP (rϭ-0.14, ns). There were significant differences in conventional risk factors and neurohumoral factors between responders and nonresponders (figure).
Conclusion:
Candesartan might obtain the reduction of morning BP. It is impossible to recognize the difference that the effect of BP reduction for angiotensin II receptor antagonists is accepted in patient background. 
